Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03503396 · ClinicalTrials.gov registry record · NA

Alcohol Impaired Driving in the Natural Environment

A NA study, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT03503396: Completed NA study, sponsored by University of Missouri-Columbia.

NCT03503396 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03503396, a NA study, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This is a pilot study to set up a larger investigation examining predictors of the decision to drive after consuming alcohol. All participants will carry a study provided smartphone and breathalyzer device for the 2 week period of the study. The intervention is that participants are randomly assigned to one of 2 breathalyzer feedback conditions - one where they receive a warning that their results indicate they should not drive and one where they receive no feedback. The study is designed to provide information needed for a larger version with a similar protocol, but also to provide an initial test of project hypotheses as well.

Primary Outcome

Change in number of times driven after drinking per week from pre (4 week TLFB) to post (2 week TLFB). A Timeline Followback (TLFB) is an interview where the participant self-reports their drinking behavior including: where they were drinking, how much they drank of what over what period of time, what location they went to next, how they got there.

Interventions

  • BEHAVIORAL BAC Driving Feedback/Warning
  • BEHAVIORAL No Feedback

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2018-04-02
Est. Completion 2019-01-20
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT03503396 record still lists

NCT03503396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which BAC Driving Feedback/Warning is the first listed.

NCT03503396 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03503396 about?

NCT03503396 is a clinical study titled "Alcohol Impaired Driving in the Natural Environment". This is a pilot study to set up a larger investigation examining predictors of the decision to drive after consuming alcohol. All participants will carry a study provided smartphone and breathalyzer device for the 2 week period of the study. The intervention is that participants are randomly assigne...

What is the current status of trial NCT03503396?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-04-02. Estimated completion is 2019-01-20.

What interventions are being tested in trial NCT03503396?

The interventions under investigation include: BAC Driving Feedback/Warning (BEHAVIORAL), No Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT03503396?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03503396's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03503396, the US trial registry maintained by the National Library of Medicine. NCT03503396 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.